| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.41 | 5e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |